Apply for Research Funding

 Our mission is to deliver treatments and cures for CMT in our lifetime. We fund the most promising research for CMT that leads to the development of therapeutics for all types of CMT.

Our research priorities drive our funding decisions, however, if you have an interesting approach or idea, we want to hear from you.

GENERAL APPLICATION INFORMATION

CMTRF is in active review of proposals from our current funding cycle, selecting the next generation of projects that will bring us closer to treatments and cures for CMT. We’re refining our general application process to make it even stronger for the researchers and partners we work with, and we’ll post updated details here in October. We look forward to welcoming new ideas soon.

Application Information: Full proposals are accepted on a quarterly basis.

For program-related or application submission inquiries, please email Kate Andersh at [email protected].

Before submitting a full proposal, applicants must first submit a Letter of Intent. The LOI submission link can be found in the resources below. An invitation to submit a full proposal is typically issued three weeks after LOI submission. To allow ample time for proposal development and to incorporate feedback from CMTRF’s Scientific Advisory Board, applicants are encouraged to submit the LOI as early as possible. Final project approvals are contingent upon successful negotiation and agreement of contract terms.

Average Award Duration: One to three years with potential for follow-on funding. Proposals for projects longer than one year in duration should include clearly defined, event-based milestones that serve as decisions points for continuing the project as planned or revising the project to reflect data gathered in initial stages.

Average Award Amount: Typical awards will range from $100,000 to $200,000 per year, based on stage and scope of research. Exceptional proposals with higher budgets are also considered. For studies requiring additional support, co-funding from other funding agencies, companies or investors is encouraged. Please identify cost-sharing opportunities in the LOI.

Eligibility: Funding is open to researchers and clinicians worldwide. Academic medical centers, universities, non-profit and for-profit research organizations are encouraged to apply. Biotechnology companies with an interest in CMT therapeutic development are especially encouraged to submit applications. Funding to for-profit organizations is provided when the project aligns with the mission of the CMT Research Foundation. Funding by the CMT Research Foundation requires the potential for a return on investment if resulting intellectual property becomes commercially profitable.

The CMT Research Foundation utilizes an iterative application process, where our CMT and industry advisors can provide advice for improving submissions when necessary.

 

Application Process

1. Letter of Intent

Please submit a 1-2 page letter of intent (PDF format) through our online portal. Highlight the specific aims of the project and the milestones expected to be reached after each stage. Identify any collaborations with companies or institutions that may advance the findings or may co-fund the project. We will evaluate the alignment of your project with our foundation’s mission and objectives. As previously mentioned, we strongly encourage early submission of the LOI to allow sufficient time for proposal development and incorporation of feedback from CMTRF’s SAB.

 2. Full Proposal 

After the Letter of Intent review, you may be invited to submit a full proposal (PDF format) that includes:

  • Lay Summary
  • Scientific Summary and Rationale
  • Specific Aims
  • Background
  • Preliminary Results
  • Detailed Experimental Plan
  • References
  • Gantt Chart of Proposed Experimental Plan
  • Detailed Budget with Justification*
  • Other Support (Current and Pending)
  • NIH biosketches for the Research Team(s)

You will receive feedback generally within three to eight weeks from submission regarding the status of your proposal after review by the SAB.

*The CMT Research Foundation will fund indirect costs up to 10%.

Each cycle, CMTRF’s George and Cleary Simpson Award for Emerging Researchers is given to one early-career researcher working within a specific research focus area. The grant is for $75,000.

Each cycle centers on a specific challenge, topic, or priority selected annually by CMTRF’s research and drug development team and aligned with CMTRF’s scientific priorities.

Within the year’s focus area, applicants are strongly encouraged to bring bold, creative, and innovative approaches. Collaborative projects between research groups, and between academic and industry investigators, are highly encouraged.

Learn more.